|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"hsu c"
Showing items 686-735 of 881 (18 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T04:09:32Z |
Quasiregular quantum-dot-like structure formation with postgrowth thermal annealing of InGaN/GaN quantum wells
|
Ma, K.-J.; Hsu, C.; Chung, Y.-Y.; Liu, C.-W.; Feng, S.-W.; Cheng, Y.-C.; Yang, C.C.; Mao, M.-H.; Chuang, H.-W.; Kuo, C.-T.; Tsang, J.-S.; Weirich, T.E.; Lin, Y.-S.; MING-HUA MAO; CHIH-WEN LIU; CHIH-CHUNG YANGet al. |
| 臺大學術典藏 |
2018-09-10T04:04:33Z |
HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity
|
Hsu, C.;Huang, C.-L.;Hsu, H.-C.;Lee, P.-H.;Wang, S.-J.;Cheng, A.-L.; PO-HUANG LEE; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T03:45:16Z |
Two-component photoluminescence decay and carrier localization in InGaN/GaN multiple quantum well structures
|
Feng, S.-W.; Cheng, Y.-C.; Yang, C.C.; Tsai, C.-Y.; Lin, Y.-S.; Hsu, C.; Ma, K.-J.; Chyi, J.-I.; CHIH-CHUNG YANG |
| 臺大學術典藏 |
2018-09-10T03:45:16Z |
Study on microstructures of InGaN/GaN multiple quantum wells
|
Lin, Y.-.S.; Hsu, C.; Ma, K.-J.; Yang, C.C.; CHIH-CHUNG YANG |
| 臺大學術典藏 |
2018-09-10T03:27:16Z |
Dependence of composition fluctuation on indium content in InGaN/GaN multiple quantum wells
|
Chyi, J.-I.; CHIH-CHUNG YANG; Lin, Y.-S.; Ma, K.-J.; Hsu, C.; Feng, S.-W.; Cheng, Y.-C.; Liao, C.-C.; Yang, C.C.; Chou, C.-C.; Lee, C.-M. |
| 國立交通大學 |
2018-08-21T05:53:23Z |
Cytoplasmic Ran regulates acentrosomal microtubule nucleation in neurons.
|
Hsu, C.; Chiu, H.; Chen, W.; Chen, Y.; Huang, Y.; Hsieh, B.; Hwang, E. |
| 國家衛生研究院 |
2018-03-15 |
Quantification of HBV core antibodies may help predict HBV reactivation in lymphoma patients with resolved HBV infection
|
Yang, HC;Tsou, HH;Pei, SN;Chang, CS;Chen, JH;Yao, M;Lin, SJ;Lin, J;Yuan, Q;Xia, N;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2018 |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
PO-HUANG LEE; Wu C.-C.; Huo T.-I.; Liao L.-Y.; Huang S.-F.; Hung C.-F.; Yang S.-S.; Chen R.-C.; Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Po-Huang Lee;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Cheng J.C.-H.;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Ni Y.-H.;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; Chen C.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 國立成功大學 |
2018 |
Tuning the Distance of Rattle-Shaped IONP@Shell-in-Shell Nanoparticles for Magnetically-Targeted Photothermal Therapy in the Second Near-Infrared Window
|
Tsai, M.-F.;Hsu, C.;Yeh, C.-S.;Hsiao, Y.-J.;Su, C.-H.;Wang, L.-F. |
| 國立成功大學 |
2018 |
Few-layer 1T′ MoTe2 as gapless semimetal with thickness dependent carrier transport
|
Song, P.;Hsu, C.;Zhao, M.;Zhao, X.;Chang, T.-R.;Teng, J.;Lin, H.;Loh, K.P. |
| 國立成功大學 |
2018 |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Lu, S.-N.;Wang, J.-H.;Su, C.-W.;Wang, T.-E.;Dai, C.-Y.;Chen, Chen C.-H.;Chen, R.-C.;Yang, S.-S.;Hung, C.-F.;Huang, S.-F.;Liao, Liao L.-Y.;Huo, T.-I.;Wu, C.-C.;Lee, P.-H.;Ting, C.-T.;Lee, W.-C.;Chau, G.-Y.;Wang, C.-C.;Lee, K.-T.;Huang, Y.-H.;Ho, M.-C.;Lin, S.-M.;Huang, G.-T.;Chen, K.-Y.;Lin, X.-Z.;Hwang, J.-I.;Chiou, Y.-Y.;Wang, C.-K.;Hu, J.-T.;Chen, S.-C.;Liang, P.-C.;Lee, R.-C.;Wu, D.-K.;Lin, C.-Y.;Lin, C.-C.;Cheng, A.-L.;Hsu, C.;Chao, Y.;Chen, L.-T.;Wang, P.-M.;Wang, P.-M.;Hong, J.-H.;Hsu, Hsu H.-C.;Chen, S.-W.;Leung, S.W.;Cheng, J.C.-H.;Wu, J.-C.;Wu, C.-Y.;Hsu, Y.-C.;Hsu, C.-W.;Ni, Y.-H.;Lin, C.-L.;group, Local ablation;group, Surveillance;group, Diagnosis;group, Staging;group, Surgery;group, TACE/TARE/HAI;group, Target therapy/systemic therapy;group, Radiotherapy;group, Prevention;group, Drafting |
| 國家衛生研究院 |
2017-06-01 |
Interleukin-24 as a target cytokine of environmental aryl hydrocarbon receptor agonist exposure in the lung
|
Luo, YH;Kuo, YC;Tsai, MH;Ho, CC;Tsai, HT;Hsu, C;Chen, YC;Lin, P |
| 國家衛生研究院 |
2017-02 |
A phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer
|
Chiang, NJ;Chen, JS;Chen, MH;Yang, SH;Hsu, C;Yen, CJ;Tsou, HH;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2017 |
Prediction of hepatitis B virus reactivation in lymphoma patients with resolved hepatitis B virus infection who received rituximab-containing chemotherapy: The roles of antiHBc/antiHBs quantification
|
Yang, HC;Tsou, HH;Pei, SN;Chang, CS;Chen, JH;Yao, M;Lin, SJ;Lin, J;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C;Group, Taiwan Cooperative Oncology |
| 臺大學術典藏 |
2017 |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Shao Y.-Y.;Bang-Bin Chen;Ou D.-L.;Lin Z.-Z.;Hsu C.-H.;Wang M.-J.;Cheng A.-L.;Hsu C.; Shao Y.-Y.; BANG-BIN CHEN; Ou D.-L.; Lin Z.-Z.; Hsu C.-H.; Wang M.-J.; Cheng A.-L.; Hsu C. |
| 臺大學術典藏 |
2017 |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; PO-CHIN LIANG; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2017 |
Epithelioid Trophoblastic Tumor Around an Abdominal Cesarean Scar: A Pathologic and Molecular Genetic Analysis
|
Kuo K.-T.; TZU-PIN LU; Hsiue E.H.-C.;Hsu C.;Tseng L.-H.;Tzu-Pin Lu;Kuo K.-T.; Hsiue E.H.-C.; Hsu C.; Tseng L.-H. |
| 國立成功大學 |
2017 |
Application of high permeability magnetic core sensor for IoTs device
|
Hsu, C.;Huang, Y.;Hsieh, M. |
| 國立成功大學 |
2017 |
Application of Underactuated mechanism motor control in ball and beam system
|
Hsu, C.;Chang, Chang C.;Hsieh, M.;Huang, Y.;Tao, C. |
| 國立成功大學 |
2017 |
Reduction of switching loss of DC to AC power inverter with PID-like fuzzy controller
|
Hsu, C.;Chang, Chang C.;Hsieh, M.;Huang, Y.;Tao, C. |
| 國立成功大學 |
2017 |
Where are the sleeping beauties and princes in educational technology journals?
|
Huang, T.-C.;Jeng, Y.-L.;Hsu, C.;Lai, C.-F. |
| 國立成功大學 |
2016-09 |
Epigenetically regulated caveolin-1 is responsible for hyper-responsiveness to mechanical stimuli and the activation of fibrogenesis-related Runx2 in keloid fibroblasts
|
Hsu, C.; Lin, H.; Harn, I. H.; Ogawa, R.; Lee, Y. J.; McGrath, J.; Tang, M. |
| 國家衛生研究院 |
2016-05-03 |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chiang, NJ;Hsu, C;Chen, JS;Tsou, HH;Shen, YY;Chao, Y;Chen, MH;Yeh, TS;Shan, YS;Huang, SF;Chen, LT |
| 國家衛生研究院 |
2016-02 |
Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC)
|
Chiang, NJ;Tsai, KK;Chen, JS;Yang, SH;Hsu, C;Shan, YS;Chen, LT |
| 國立臺灣大學 |
2016 |
Safety and preliminary efficacy of nivolumab (nivo) in patients (pts) with advanced hepatocellular carcinoma (aHCC): Interim analysis of the phase 1/2 CheckMate-040 study
|
Melero, I.; Sangro, B.; Yau, T.; Hsu, C.; Kudo, M.; Crocenzi, T.; Kim, T-Y.; Choo, S-P.; Trojan, J.; Meyer, T.; Welling, T. H., III; Yeo, W.; Chopra, A.; Anderson, J.; Dela Cruz, C.; Lang, L.; Neely, J.; El-Khoueiry, A.; 許駿 |
| 國立臺灣大學 |
2016 |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration
|
Shao, Y-Y.; Chen, B-B.; Lin, Z-Z.; Hsu, C-H.; Wang, M-J.; Cheng, A-L.; Hsu, C.; 邵幼雲; 林宗哲; 鄭安理; 陳邦斌; 徐志宏; 許駿 |
| 臺大學術典藏 |
2016 |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
CHIH-HUNG HSU; Hsu C.; Guo J.-C.; Wu H.; Yang S.-H.;Kuo T.-C.;Wu H.;Guo J.-C.;Hsu C.;Chih-Hung Hsu;Tien Y.-W.;Yeh K.-H.;Cheng A.-L.;Kuo S.-H.; Yang S.-H.; Kuo T.-C.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H. |
| 國家衛生研究院 |
2015-12 |
Towards an endpoint cell motility assay by a microfluidic platform
|
Yeh, C;Tai, W;Lin, C;Juang, D;Wu, C;Chen, Y;Hsu, C |
| 國家衛生研究院 |
2015-12 |
A decade of changes in preferences for life-sustaining treatments among terminally Ill patients with cancer
|
Tang, ST;Liu, TW;Wen, FH;Hsu, C;Chang, YH;Chang, CS;Sung, YC;Hsieh, CI;Chang, SY;Liu, LN;Chiang, MC |
| 國家衛生研究院 |
2015-11 |
Medical care and costs of patients with systemic lupus erythematosus in Taiwan
|
Cheng, J;Huang, C;Hsu, C |
| 國家衛生研究院 |
2015-09 |
Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma
|
Ou, DL;Shyue, SK;Lin, LI;Feng, ZR;Liou, JY;Fan, HH;Lee, BS;Hsu, C;Cheng, AL |
| 國家衛生研究院 |
2015-07 |
Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review
|
Park, JO;Oh, DY;Hsu, C;Chen, JS;Chen, LT;Orlando, M;Kim, JS;Lim, HY |
| 國立成功大學 |
2015-05-01 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, J. S.; Hsu, C.; Chiang, N. J.; Tsai, C. S.; Tsou, H. H.; Huang, S. F.; Bai, L. Y.; Chang, I. C.; Shiah, H. S.; Ho, C. L.; Yen, C. J.; Lee, K. D.; Chiu, C. F.; Rau, K. M.; Yu, M. S.; Yang, Y.; Hsieh, R. K.; Chang, J. Y.; Shan, Y. S.; Chao, Y.; Chen, L. T. |
| 國家衛生研究院 |
2015-05 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, JS;Hsu, C;Chiang, NJ;Tsai, CS;Tsou, HH;Huang, SF;Bai, LY;Chang, IC;Shiah, HS;Ho, CL;Yen, CJ;Lee, KD;Chiu, CF;Rau, KM;Yu, MS;Yang, Y;Hsieh, RK;Chang, JY;Shan, YS;Chao, Y;Chen, LT |
| 國家衛生研究院 |
2015-04 |
Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide
|
Liang, PC;Ch'ang, HJ;Hsu, C;Chen, LT;Shih, TTF;Liu, TW |
| 國家衛生研究院 |
2015-04 |
Long-term outcome of chemotherapy-induced HBV reactivation in lymphoma patients with resolved HBV infection
|
Yang, HC;Tsou, HH;Chuang, MH;Chen, CL;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C |
| 國立臺灣大學 |
2015 |
LONG-TERM OUTCOME OF CHEMOTHERAPY-INDUCED HBV REACTIVATION IN LYMPHOMA PATIENTS WITH RESOLVED HBV INFECTION
|
Yang, H. -C.; Tsou, H. -H.; Chuang, M. -H.; Chen, C. -L.; Liu, T. -W.; Chen, P. -J.; Cheng, A. -L.; Hsu, C.; 鄭安理; 許駿; 陳培哲; 陳祈玲 |
| 臺大學術典藏 |
2015 |
Magnetostriction and magnetic loss variation dependent on stress for power transformer core
|
Hsu, C.;Jen, S.;Liu, J.;Fu, C.;Cheng, S.; Hsu, C.; Jen, S.; Liu, J.; Fu, C.; Cheng, S.; CHAO-MING FU |
| 臺大學術典藏 |
2015 |
The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia
|
Kuo H.-Y.;Lin Z.-Z.;Kuo R.;Shau W.-Y.;Lai C.-L.;Yang Y.-Y.;Shao Y.-Y.;Hsu C.;Wen-Fang Cheng;Cheng A.-L.;Yang J.C.H.;Lai M.-S.; Kuo H.-Y.; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; WEN-FANG CHENG; Cheng A.-L.; Yang J.C.H.; Lai M.-S. |
| 國家衛生研究院 |
2014-12-15 |
H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis
|
Wu, PC;Lu, JW;Yang, JY;Lin, IH;Ou, DL;Lin, YH;Chou, KH;Huang, WF;Wang, WP;Huang, YL;Hsu, C;Lin, LI;Lin, YM;James Shen, CK;Tzeng, TY |
| 國立交通大學 |
2014-12-08T15:25:22Z |
Low frequency noise degradation in ultra-thin oxide (I5A) analog n-MOSFETs resulting from valence-band tunneling
|
Wu, JW; You, JW; Ma, HC; Cheng, CC; Hsu, C; Huang, GW; Chang, CS; Wang, T |
| 國立成功大學 |
2014-11 |
Phase I, dose-escalation study of the investigational drug D07001-F4, an oral formulation of gemcitabine HCl, in patients (pts) with advanced solid tumors or lymphoma
|
Lin, C.; Su, W.; Lee, J.; Hsu, C.; Cheng, A.; Lin, C.; Ho, H.; Huang, C.; Hsueh, S.; Yang, J |
| 國家衛生研究院 |
2014-08 |
Two new acidic diterpenoids from the heartwood of Pinus massoniana LAMB
|
Mohamed, HA;Hsieh, CL;Hsu, C;Kuo, CC;Chang, HS;Lee, CK;Lee, TH;Wu, JB;Chang, CI;Kuo, YH |
| 國家衛生研究院 |
2014-07 |
Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians
|
Chen, P;Takeuchi, F;Lee, JY;Li, H;Wu, JY;Liang, J;Long, J;Tabara, Y;Goodarzi, MO;Pereira, MA;Kim, YJ;Go, MJ;Stram, DO;Vithana, E;Khor, CC;Liu, J;Liao, J;Ye, X;Wang, Y;Lu, L;Young, TL;Lee, J;Thai, AC;Cheng, CY;van Dam, RM;Friedlander, Y;Heng, CK;Koh, WP;Chen, CH;Chang, LC;Pan, WH;Qi, Q;Isono, M;Zheng, W;Cai, Q;Gao, Y;Yamamoto, K;Ohnaka, K;Takayanagi, R;Kita, Y;Ueshima, H;Hsiung, CA;Cui, J;Sheu, WH;Rotter, JI;Chen, YD;Hsu, C;Okada, Y;Kubo, M;Takahashi, A;Tanaka, T;van Rooij, FJ;Ganesh, SK;Huang, J;Huang, T;Yuan, J;Hwang, JY;Gross, MD;Assimes, TL;Miki, T;Shu, XO;Qi, L;Chen, YT;Lin, X;Aung, T;Wong, TY;Teo, YY;Kim, BJ;Kato, N;Tai, ES |
| 國家衛生研究院 |
2014-07 |
Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen, YC;Li, CP;Yen, CJ;Hsu, C;Lin, YL;Lin, ZZ;Chen, LT;Su, WC;Chao, Y;Yeh, KH;Cheng, AL |
| 國家衛生研究院 |
2014-06-20 |
Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity
|
Kuo, SH;Yeh, KH;Chen, LT;Lin, CW;Hsu, PN;Hsu, C;Wu, MS;Tzeng, YS;Tsai, HJ;Wang, HP;Cheng, AL |
| 國家衛生研究院 |
2014-06 |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Hsu, C;Tsou, HH;Lin, SJ;Wang, MC;Yao, M;Hwang, WL;Kao, WY;Chiu, CF;Lin, SF;Lin, J;Chang, CS;Tien, HF;Liu, TW;Chen, PJ;Cheng, AL |
| 國立成功大學 |
2014-06 |
Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity
|
Kuo, S-H; Yeh, K-H; Chen, L-T; Lin, C-W; Hsu, P-N; Hsu, C.; Wu, M-S; Tzeng, Y-S; Tsai, H-J; Wang, H-P; Cheng, A-L |
| 國家衛生研究院 |
2014-04 |
Prevention of chemotherapy-induced hbv-related hepatitis flare in lymphoma patients with resolved hbv infection: Cost analysis
|
Tsou, HH;Yang, HC;Chuang, MH;Wu, HY;Hsu, YT;Chang, WJ;Hsiao, CF;Hsu, C;Grp, Taiwan Cooperative Oncology |
| 國家衛生研究院 |
2014-01-03 |
Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: The role of survivin
|
Ou, DL;Lee, BS;Lin, LI;Liou, JY;Liao, SC;Hsu, C;Cheng, AL |
Showing items 686-735 of 881 (18 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page
|
